Insider · CIK 0001813800

Fairman Jeff

Reports to the SEC for 1 company · FOSTER CITY, CA

sec.gov

Transactions

Companies

Filings

CIK

0001813800

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-12-30	PCVXVaxcyte, Inc. · Stock Option (Right to Buy)A Award	VP, Research	AAward	+15K sh	—	—	15,000
2022-10-26	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−10K sh	$40.00	−$400K	286,227
2022-10-11	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−5,000 sh	$25.50	−$128K	296,227
2022-09-06	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−4,664 sh	$26.54	−$124K	301,563
2022-09-06	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−336 sh	$27.14	−$9,118.435	301,227
2022-09-02	PCVXVaxcyte, Inc.F Tax Payment	VP, Research	FTax Payment	−519 sh	$26.38	−$13.7K	17,143
2022-08-05	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−5,000 sh	$25.70	−$129K	306,227
2022-08-04	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−10K sh	$25.50	−$255K	311,227
2022-05-20	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−4,112 sh	$25.50	−$105K	321,227
2022-05-05	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−888 sh	$25.80	−$22.9K	325,339
2022-04-05	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−5,000 sh	$25.59	−$128K	326,227
2022-03-11	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−10K sh	$25.50	−$255K	331,227
2022-03-02	PCVXVaxcyte, Inc.A Award	VP, Research	AAward	+6,000 sh	—	—	16,629
2022-03-02	PCVXVaxcyte, Inc. · Stock Option (right to buy)A Award	VP, Research	AAward	+33K sh	—	—	33,000
2021-12-27	PCVXVaxcyte, Inc.M Exercise/Conversion	VP, Research	MExercise/Conversion	+4,750 sh	$1.79	+$8,502.5	10,910
2021-12-27	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−4,575 sh	$23.58	−$108K	6,335
2021-12-27	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−175 sh	$24.08	−$4,214	6,160
2021-12-27	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	VP, Research	MExercise/Conversion	−4,750 sh	—	—	53,345
2021-12-20	PCVXVaxcyte, Inc.M Exercise/Conversion	VP, Research	MExercise/Conversion	+4,469 sh	$1.79	+$7,999.51	10,629
2021-12-20	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	VP, Research	MExercise/Conversion	−4,469 sh	—	—	53,626
2021-12-16	PCVXVaxcyte, Inc.M Exercise/Conversion	VP, Research	MExercise/Conversion	+4,619 sh	$1.79	+$8,268.01	10,779
2021-12-16	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−4,619 sh	$22.50	−$104K	6,160
2021-12-16	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	VP, Research	MExercise/Conversion	−4,619 sh	—	—	58,095
2021-12-09	PCVXVaxcyte, Inc.M Exercise/Conversion	VP, Research	MExercise/Conversion	+131 sh	$1.79	+$234.49	6,291
2021-12-09	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−131 sh	$22.50	−$2,947.5	6,160
2021-12-09	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	VP, Research	MExercise/Conversion	−131 sh	—	—	62,714
2021-10-26	PCVXVaxcyte, Inc.M Exercise/Conversion	VP, Research	MExercise/Conversion	+4,750 sh	$1.79	+$8,502.5	9,894
2021-10-26	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−4,750 sh	$22.69	−$108K	5,144
2021-10-26	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	VP, Research	MExercise/Conversion	−4,750 sh	—	—	62,845
2021-09-27	PCVXVaxcyte, Inc.M Exercise/Conversion	VP, Research	MExercise/Conversion	+4,750 sh	$1.79	+$8,502.5	9,894
2021-09-27	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−4,611 sh	$26.16	−$121K	5,283
2021-09-27	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−139 sh	$26.47	−$3,679.33	5,144
2021-09-27	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	VP, Research	MExercise/Conversion	−4,750 sh	—	—	67,595
2021-08-26	PCVXVaxcyte, Inc.M Exercise/Conversion	VP, Research	MExercise/Conversion	+4,750 sh	$1.79	+$8,502.5	9,894
2021-08-26	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−1,532 sh	$24.70	−$37.8K	8,362
2021-08-26	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−3,218 sh	$25.70	−$82.7K	5,144
2021-08-26	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	VP, Research	MExercise/Conversion	−4,750 sh	—	—	72,345
2021-07-26	PCVXVaxcyte, Inc.M Exercise/Conversion	VP, Research	MExercise/Conversion	+4,750 sh	$1.79	+$8,502.5	9,894
2021-07-26	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−4,750 sh	$22.70	−$108K	5,144
2021-07-26	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	VP, Research	MExercise/Conversion	−4,750 sh	—	—	77,095
2021-06-28	PCVXVaxcyte, Inc.M Exercise/Conversion	VP, Research	MExercise/Conversion	+4,750 sh	$1.79	+$8,502.5	9,894
2021-06-28	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−4,614 sh	$24.36	−$112K	5,280
2021-06-28	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−136 sh	$24.80	−$3,372.8	5,144
2021-06-28	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	VP, Research	MExercise/Conversion	−4,750 sh	—	—	81,845
2021-06-07	PCVXVaxcyte, Inc.M Exercise/Conversion	VP, Research	MExercise/Conversion	+7,259 sh	$0.04	+$290.36	12,403
2021-06-07	PCVXVaxcyte, Inc.M Exercise/Conversion	VP, Research	MExercise/Conversion	+2,241 sh	$1.79	+$4,011.39	14,644
2021-06-07	PCVXVaxcyte, Inc.S Sale	VP, Research	SSale	−9,500 sh	$22.50	−$214K	5,144
2021-06-07	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	VP, Research	MExercise/Conversion	−7,259 sh	—	—	0
2021-06-07	PCVXVaxcyte, Inc. · Stock Option (right to buy)M Exercise/Conversion	VP, Research	MExercise/Conversion	−2,241 sh	—	—	86,595
2021-04-22	PCVXVaxcyte, Inc.M Exercise/Conversion	VP, Research	MExercise/Conversion	+2,793 sh	$1.79	+$4,999.47	4,201

Recent filings

Accepted (ET)
Jan 44
Fairman Jeff0001209191-23-000968
SEC(opens sec.gov)
Oct 284
Fairman Jeff0001209191-22-054858
SEC(opens sec.gov)
Oct 134
Fairman Jeff0001209191-22-053579
SEC(opens sec.gov)
Sep 74
Fairman Jeff0001209191-22-049025
SEC(opens sec.gov)
Aug 54
Fairman Jeff0001209191-22-044659
SEC(opens sec.gov)
May 244
Fairman Jeff0001209191-22-031619
SEC(opens sec.gov)
May 94
Fairman Jeff0001209191-22-027848
SEC(opens sec.gov)
Apr 74
Fairman Jeff0001209191-22-023695
SEC(opens sec.gov)
Mar 154
Fairman Jeff0001209191-22-019027
SEC(opens sec.gov)
Mar 44
Fairman Jeff0001209191-22-016524
SEC(opens sec.gov)
Feb 84
Fairman Jeff0001209191-22-007789
SEC(opens sec.gov)
Dec 284
Fairman Jeff0001209191-21-071376
SEC(opens sec.gov)

Companies

Vaxcyte, Inc.VP, ResearchPCVX

Address

C/O VAXCYTE, INC. 353 HATCH DRIVE

FOSTER CITY, CA, 94404